|
1
|
Provenzale D, Jasperson K, Ahnen DJ,
Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford
JM, et al: Colorectal cancer screening, version 1.2015. J Natl
Compr Canc Netw. 13:959–968. 2015.PubMed/NCBI
|
|
2
|
Gastrointestinal surgery group; Colorectal
and anal surgery group; Colorectal cancer Specialized Committee:
Guidelines for diagnosis and comprehensive treatment of colorectal
cancer liver metastases (V 2013). Zhonghua wei chang wai ke za zhi.
16:780–788. 2013.In Chinese.
|
|
3
|
Association of Digestive Endoscopy, Cancer
endoscopy Specialized Committee: Guidelines for early colorectal
cancer screening and endoscopic diagnosis and treatment in China
(2014). Nat Med J China. 95:2235–2252. 2015.In Chinese.
|
|
4
|
Polyak K and Hahn WC: Roots and stems:
stem cells in cancer. Nat Med. 12:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li F, Tiede B, Massagué J and Kang Y:
Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res.
17:3–14. 2007. View Article : Google Scholar
|
|
6
|
Kakarala M and Wicha MS: Implications of
the cancer stem-cell hypothesis for breast cancer prevention and
therapy. J Clin Oncol. 26:2813–2820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
9
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
12
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
13
|
Chu P, Clanton DJ, Snipas TS, Lee J,
Mitchell E, Nguyen ML, Hare E and Peach RJ: Characterization of a
subpopulation of colon cancer cells with stem cell-like properties.
Int J Cancer. 124:1312–1321. 2009. View Article : Google Scholar
|
|
14
|
Laganà AS, Colonese F, Colonese E, Sofo V,
Salmeri FM, Granese R, Chiofalo B, Ciancimino L and Triolo O:
Cytogenetic analysis of epithelial ovarian cancer's stem cells: an
overview on new diagnostic and therapeutic perspectives. Eur J
Gynaecol Oncol. 36:495–505. 2015.PubMed/NCBI
|
|
15
|
López J, Valdez-Morales FJ,
Benítez-Bribiesca L, Cerbón M and Carrancá AG: Normal and cancer
stem cells of the human female reproductive system. Reprod Biol
Endocrinol. 11:532013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jing F, Kim HJ, Kim CH, Kim YJ, Lee JH and
Kim HR: Colon cancer stem cell markers CD44 and CD133 in patients
with colorectal cancer and synchronous hepatic metastases. Int J
Oncol. 46:1582–1588. 2015.PubMed/NCBI
|
|
17
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Birchmeier W and Birchmeier C:
Epithelial-mesenchymal transitions in development and tumor
progression. EXS. 74:1–15. 1995.PubMed/NCBI
|
|
19
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jacobs JJ and van Lohuizen M: Polycomb
repression: from cellular memory to cellular proliferation and
cancer. Biochim Biophys Acta. 1602:151–161. 2002.PubMed/NCBI
|
|
21
|
Piunti A and Pasini D: Epigenetic factors
in cancer development: polycomb group proteins. Future Oncol.
7:57–75. 2011. View Article : Google Scholar
|
|
22
|
Honig A, Weidler C, Häusler S,
Krockenberger M, Buchholz S, Köster F, Segerer SE, Dietl J and
Engel JB: Overexpression of polycomb protein BMI-1 in human
specimens of breast, ovarian, endometrial and cervical cancer.
Anticancer Res. 30:1559–1664. 2010.PubMed/NCBI
|
|
23
|
Vékony H, Raaphorst FM, Otte AP, van
Lohuizen M and Leemans CR: High expression of Polycomb group
protein EZH2 predicts poor survival in salivary gland adenoid
cystic carcinoma. J Clin Pathol. 61:744–749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Silva J, García JM, Peña C, García V,
Domínguez G, Suárez D, Camacho FI, Espinosa R, Provencio M, España
P and Bonilla F: Implication of polycomb members Bmi-1, Mel-18, and
Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc
expression in primary breast carcinomas. Clin Cancer Res.
12:6929–6936. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Molofsky AV, Pardal R, Iwashita T, Park
IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes
neural stem cell self-renewal from progenitor proliferation.
Nature. 425:962–967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu XH, Sha WH, Lin F, Cen RY and Liao SY:
The correlation between genetic expressions of Bmi-1 and
clinicopathological parameters of colorectal cancer. Modern
Digestion & Intervention. 16:1–5. 2011.In Chinese.
|
|
27
|
Yang J, Liu J, Lyu X and Fei S:
Resveratrol inhibits cell proliferation and up-regulates MICA/B
expression in human colon cancer stem cells. Xi Bao Yu Fen Zi Mian
Yi Xue Za Zhi. 31:889–893. 2015.In Chinese. PubMed/NCBI
|
|
28
|
Xiong B, Ma L, Hu X, Zhang C and Cheng Y:
Characterization of side population cells isolated from the colon
cancer cell line SW480. Int J Oncol. 45:1175–1183. 2014.PubMed/NCBI
|
|
29
|
Feng Y, Dai X, Li X, Wang H, Liu J, Zhang
J, Du Y and Xia L: EGF signalling pathway regulates colon cancer
stem cell proliferation and apoptosis. Cell Prolif. 45:413–419.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou M, Lu Y, Yuan L, Zheng L, Liu Y, Hong
M, Zhang C and Li X: Preliminary screening of downstream proteins
of Sox2 and role of Sox2 in colonic cancer cell migration and
invasion. Nan Nan Fang Yi Ke Da Xue Xue Bao. 34:1594–1600. 2014.In
Chinese.
|
|
31
|
Zhang M, Cui F, Lu S, Lu H, Xue Y, Wang J,
Chen J, Zhao S, Ma S, Zhang Y, et al: Developmental
pluripotency-associated 4: a novel predictor for prognosis and a
potential therapeutic target for colon cancer. J Exp Clin Cancer
Res. 34:602015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie X, Zhao Y, Ma CY, Xu XM, Zhang YQ,
Wang CG, Jin J, Shen X, Gao JL, Li N, et al: Dimethyl fumarate
induces necroptosis in colon cancer cells through GSH depletion/ROS
increase/MAPKs activation pathway. Br J Pharmacol. 172:3929–3943.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin YU, Wu T, Yao Q, Zi S, Cui L, Yang M
and Li J: LGR5 promotes the proliferation of colorectal cancer
cells via the Wnt/β-catenin signaling pathway. Oncol Lett.
9:2859–2863. 2015.PubMed/NCBI
|
|
34
|
Peng HX, Wu WQ, Yang DM, Jing R, Li J,
Zhou FL, Jin YF, Wang SY and Chu YM: Role of B7-H4 siRNA in
proliferation, migration, and invasion of LOVO colorectal carcinoma
cell line. BioMed Res Int. 2015:3269812015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeng L, Qiu L, Yang XT, Zhou YH, Du J,
Wang HY, Sun JH, Yang C and Jiang JX: Isolation of lung multipotent
stem cells using a novel microfluidic magnetic activated cell
sorting system. Cell Biol Int. 39:1348–1353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xue ZX, Zheng JH, Zheng ZQ, Cai JL, Ye XH,
Wang C, Sun WJ, Zhou X, Lu MD, Li PH and Cai ZZ: Latexin inhibits
the proliferation of CD133+ miapaca-2 pancreatic cancer
stem-like cells. World J Surg Oncol. 12:1–11. 2014. View Article : Google Scholar
|
|
37
|
Zhang DG, Jiang AG, Lu HY, Zhang LX and
Gao XY: Isolation, cultivation and identification of human lung
adenocarcinoma stem cells. Oncol Lett. 9:47–54. 2015.
|
|
38
|
Levin TG, Powell AE, Davies PS, Silk AD,
Dismuke AD, Anderson EC, Swain JR and Wong MH: Characterization of
the intestinal cancer stem cell marker CD166 in the human and mouse
gastrointestinal tract. Gastroenterology. 139:2072–2082. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Femia AP, Dolara P, Salvadori M and
Caderni G: Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem
cell markers, in the early phases of 1,2-dimethylhydrazine-induced
rat colon carcinogenesis: correlation with nuclear β-catenin. BMC
Cancer. 13:482013. View Article : Google Scholar
|
|
41
|
Yui S, Nakamura T, Sato T, Nemoto Y,
Mizutani T, Zheng X, Ichinose S, Nagaishi T, Okamoto R, Tsuchiya K,
et al: Functional engraftment of colon epithelium expanded in vitro
from a single adult Lgr5+ stem cell. Nat Med.
18:618–623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Barker N, van Es JH, Kuipers J, Kujala P,
van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H,
Peters PJ and Clevers H: Identification of stem cells in small
intestine and colon by marker gene Lgr5. Nature. 449:1003–1007.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vermeulen L, Todaro M, de Sousa Mello F,
Sprick MR, Kemper K, Perez Alea M, Richel DJ, Stassi G and Medema
JP: Single-cell cloning of colon cancer stem cells reveals a
multi-lineage differentiation capacity. Proc Natl Acad Sci USA.
105:13427–13432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fric P, Sovová V, Sloncová E, Lojda Z,
Jirásek A and Cermák J: Different expression of some molecular
markers in sporadic cancer of the left and right colon. Eur J
Cancer Prev. 9:265–268. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pang R, Law WL, Chu AC, Poon JT, Lam CS,
Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, et al: A subpopulation of
CD26+ cancer stem cells with metastatic capacity in
human colorectal cancer. Cell Stem Cell. 6:603–615. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fujimoto K, Beauchamp RD and Whitehead RH:
Identification and isolation of candidate human colonic clonogenic
cells based on cell surface integrin expression. Gastroenterology.
123:1941–1948. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lugli A, Iezzi G, Hostettler I, Muraro MG,
Mele V, Tornillo L, Carafa V, Spagnoli G, Terracciano L and Zlobec
I: Prognostic impact of the expression of putative cancer stem cell
markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Br J Cancer. 103:382–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dylla SJ, Beviglia L, Park IK, Chartier C,
Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S,
et al: Colorectal cancer stem cells are enriched in xenogeneic
tumors following chemotherapy. PLoS One. 3:e24282008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Park IH, Zhao R, West JA, Yabuuchi A, Huo
H, Ince TA, Lerou PH, Lensch MW and Daley GQ: Reprogramming of
human somatic cells to pluripotency with defined factors. Nature.
451:141–146. 2008. View Article : Google Scholar
|
|
51
|
Saigusa S, Tanaka K, Toiyama Y, Yokoe T,
Okugawa Y, Ioue Y, Miki C and Kusunoki M: Correlation of CD133,
OCT4, and SOX2 in rectal cancer and their association with distant
recurrence after chemoradiotherapy. Ann Surg Oncol. 16:3488–3498.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ziskin JL, Dunlap D, Yaylaoglu M, Fodor
IK, Forrest WF, Patel R, Ge N, Hutchins GG, Pine JK, Quirke P, et
al: In situ validation of an intestinal stem cell signature in
colorectal cancer. Gut. 62:1012–1023. 2013. View Article : Google Scholar
|
|
53
|
Zhu R, Yang Y, Tian Y, Bai J, Zhang X, Li
X, Peng Z, He Y, Chen L, Pan Q, et al: Ascl2 knockdown results in
tumor growth arrest by miRNA-302b-related inhibition of colon
cancer progenitor cells. PLoS One. 7:e321702012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jubb AM, Chalasani S, Frantz GD, Smits R,
Grabsch HI, Kavi V, Maughan NJ, Hillan KJ, Quirke P and Koeppen H:
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is
upregulated in intestinal neoplasia. Oncogene. 25:3445–3457. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Reedijk M, Odorcic S, Zhang H, Chetty R,
Tennert C, Dickson BC, Lockwood G, Gallinger S and Egan SE:
Activation of Notch signaling in human colon adenocarcinoma. Int J
Oncol. 33:1223–1229. 2008.PubMed/NCBI
|
|
56
|
Gao F, Zhang Y, Wang S, Liu Y, Zheng L,
Yang J, Huang W, Ye Y, Luo W and Xiao D: Hes1 is involved in the
self-renewal and tumourigenicity of stem-like cancer cells in colon
cancer. Sci Rep. 4:39632014.PubMed/NCBI
|
|
57
|
Vermeulen L, De Sousa E, Melo F, van der
Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M,
Merz C, Rodermond H, et al: Wnt activity defines colon cancer stem
cells and is regulated by the microenvironment. Nat Cell Biol.
12:468–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu
LJ, Kong QL, Xu LH, Zhang X, Liu WL, et al: The polycomb group
protein Bmi-1 represses the tumor suppressor PTEN and induces
epithelial-mesenchymal transition in human nasopharyngeal
epithelial cells. J Clin Invest. 119:3626–3636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li H, Song F, Chen X, Li Y, Fan J and Wu
X: Bmi-1 regulates epithelial-to-mesenchymal transition to promote
migration and invasion of breast cancer cells. Int J Clin Exp
Pathol. 7:3057–3064. 2014.PubMed/NCBI
|
|
60
|
Guo BH, Feng Y, Zhang R, Xu LH, Li MZ,
Kung HF, Song LB and Zeng MS: Bmi-1 promotes invasion and
metastasis, and its elevated expression is correlated with an
advanced stage of breast cancer. Mol Cancer. 10:102011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu S, Tetzlaff MT, Cui R and Xu X:
miR-200c inhibits melanoma progression and drug resistance through
down-regulation of BMI-1. Am J Pathol. 181:1823–1835. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Nanta R, Kumar D, Meeker D, Rodova M, Van
Veldhuizen PJ, Shankar S and Srivastava RK: NVP-LDE-225
(Erismodegib) inhibits epithelial-mesenchymal transition and human
prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by
regulating Bmi-1 and microRNA-128. Oncogenesis. 2:e422013.
View Article : Google Scholar
|
|
64
|
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen
L, Chen H and Liu J: miR-200c inhibits invasion, migration and
proliferation of bladder cancer cells through down-regulation of
BMI-1 and E2F3. J Transl Med. 12:3052014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dass SD, Cheah PL, Ong DB, Teoh KH and
Looi LM: E-cadherin downregulation at the infiltrating tumour front
is associated with histological grade and stage in colorectal
carcinoma of Malaysians. Malays J Pathol. 37:19–24. 2015.PubMed/NCBI
|
|
66
|
Le Bras GF, Taubenslag KJ and Andl CD: The
regulation of cell-cell adhesion during epithelial-mesenchymal
transition, motility and tumor progression. Cell Adh Migr.
6:365–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liao WT, Cui YM and Ding YQ: Expression
and Significance of Bmi-1 PTEN and E-Cadherin in Colorectal Cancer.
Chin J Clin Oncol. 39:559–563. 2012.In Chinese.
|
